Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model
Sapana Bansod, Mohd Aslam Saifi, Chandraiah Godugu
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis
Xiaoli Li, Qianqian Li, Xiong Bin, et al.
Pharmacological Research (2022) Vol. 183, pp. 106368-106368
Closed Access | Times Cited: 35
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
Hiroyoshi Tanaka, Takuya Nakazawa, Atsushi Enomoto, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 724-724
Open Access | Times Cited: 14
Activation and Regulation of Pancreatic Stellate Cells in Chronic Pancreatic Fibrosis: A Potential Therapeutic Approach for Chronic Pancreatitis
Fanyi Kong, Yingyu Pan, Dong Wu
Biomedicines (2024) Vol. 12, Iss. 1, pp. 108-108
Open Access | Times Cited: 5
Stromal Cells in Early Inflammation-Related Pancreatic Carcinogenesis—Biology and Its Potential Role in Therapeutic Targeting
Tina Seidel, Nupur Ohri, Markus Glaß, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1541-1541
Open Access
Pancreatic Stellate Cells and the Targeted Therapeutic Strategies in Chronic Pancreatitis
Man Chang, Wenjuan Chen, Ruting Xia, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5586-5586
Open Access | Times Cited: 9
Discoidin domain receptor 1 as a potent therapeutic target in solid tumors
Shaheen Bibi, Weihong Zeng, Peiyi Zheng, et al.
hLife (2024) Vol. 2, Iss. 9, pp. 454-466
Open Access | Times Cited: 2
Exploring the pathogenesis, biomarkers, and potential drugs for type 2 diabetes mellitus and acute pancreatitis through a comprehensive bioinformatic analysis
Lei Zhong, Xi Yang, Yu‐Xuan Shang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds
Yang Wu, Chun Zhang, Mei Guo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease
Corina M. Borza, Gema Bolás, Ambra Pozzi
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Berberine Attenuates Cerulein‐Induced Acute Pancreatitis by Modulating Nrf2/NOX2 Signaling Pathway via AMPK Activation
Sapana Bansod, Mohd Aslam Saifi, Shrilekha Chilvery, et al.
Environmental Toxicology (2024)
Closed Access
Discoidin domain receptor 1 may be involved in biological barrier homeostasis
Xiaoli Li, Huiling Chen, Dekui Zhang
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 12, pp. 2397-2407
Closed Access | Times Cited: 2
Page 1

Scroll to top